(Q44729660)

5 December 2017

title

CD133+ cell content correlates with tumour growth in melanomas from skin with chronic sun-induced damage (English)

1 reference

5 December 2017

author

Isidro Sanchez-garcia

7

1 reference

5 December 2017

I González-Herrero

1

1 reference

5 December 2017

I Romero-Camarero

2

1 reference

5 December 2017

J Cañueto

3

1 reference

5 December 2017

E Cardeñoso-Álvarez

4

1 reference

5 December 2017

E Fernández-López

5

1 reference

5 December 2017

J Pérez-Losada

6

1 reference

5 December 2017

C Román-Curto

8

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 October 2013

1 reference

British Journal of Dermatology

5 December 2017

published in

1 reference

5 December 2017

volume

169

1 reference

5 December 2017

issue

4

1 reference

5 December 2017

page(s)

830-837

1 reference

Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma

5 December 2017

cites work

1 reference

21 January 2018

Cancer statistics, 2006

1 reference

Final version of 2009 AJCC melanoma staging and classification

21 January 2018

1 reference

Distinct sets of genetic alterations in melanoma

21 January 2018

1 reference

Stem-like cancer cells are inducible by increasing genomic instability in cancer cells

21 January 2018

1 reference

Efficient tumour formation by single human melanoma cells

21 January 2018

1 reference

Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery.

21 January 2018

1 reference

Immuno-expression of human melanoma stem cell markers in tissues at different stages of the disease

21 January 2018

1 reference

Melanoma stem cells: the dark seed of melanoma

21 January 2018

1 reference

Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential.

21 January 2018

1 reference

Increased expression of stem cell markers in malignant melanoma.

21 January 2018

1 reference

The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma

21 January 2018

1 reference

CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche

21 January 2018

1 reference

The chemokine receptor CXCR4 and the metalloproteinase MT1-MMP are mutually required during melanoma metastasis to lungs.

21 January 2018

1 reference

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

The theoretical basis of cancer-stem-cell-based therapeutics of cancer: can it be put into practice?

21 January 2018

1 reference

Recent advances in cancer stem cells

21 January 2018

1 reference

Malignant melanoma in the 21st century: the emerging molecular landscape

21 January 2018

1 reference

Classifying Melanocytic Tumors Based on DNA Copy Number Changes

21 January 2018

1 reference

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

Putative cancer stem cells in cutaneous malignancies

21 January 2018

1 reference

Identification of cells initiating human melanomas

21 January 2018

1 reference

Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis

21 January 2018

1 reference

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

21 January 2018

1 reference

Development of a unique small molecule modulator of CXCR4

21 January 2018

1 reference

MEK1 mutations confer resistance to MEK and B-RAF inhibition

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJD.12428

1 reference

5 December 2017

1 reference